MediXall Group, Inc. (MDXL)
OTCMKTS · Delayed Price · Currency is USD
0.0056
0.00 (0.00%)
At close: Jun 1, 2026
MediXall Group Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 0.03 | 0.01 | 0 | 0.06 | 0.65 | 0.45 |
Cash & Short-Term Investments | 0.03 | 0.01 | 0 | 0.06 | 0.65 | 0.45 |
Cash Growth | 230.15% | 213.85% | -94.61% | -90.18% | 44.72% | 121.44% |
Receivables | 0.01 | - | - | - | - | - |
Prepaid Expenses | - | - | - | 0.28 | 0.48 | - |
Other Current Assets | 0 | 0 | 0.01 | 0 | 0.01 | - |
Total Current Assets | 0.05 | 0.01 | 0.01 | 0.34 | 1.13 | 0.45 |
Property, Plant & Equipment | 0.03 | 0.01 | 0.28 | 0.34 | 0.07 | 0.14 |
Other Intangible Assets | 0.14 | 0.17 | 0.57 | 0.45 | 0.44 | 0.36 |
Total Assets | 0.22 | 0.2 | 0.86 | 1.13 | 1.64 | 0.94 |
Liabilities
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Accounts Payable | 2.12 | 2.82 | 1.1 | 0.59 | 0.57 | 0.16 |
Accrued Expenses | - | - | 0.06 | 0.02 | 0.02 | 0.26 |
Short-Term Debt | - | - | - | - | 0.03 | - |
Current Portion of Long-Term Debt | 0.55 | 3.83 | 2.56 | - | - | - |
Current Portion of Leases | 0.01 | - | 0.08 | 0.07 | 0.05 | 0.07 |
Other Current Liabilities | 1.11 | 0.07 | 0.55 | 0.55 | 0.46 | - |
Total Current Liabilities | 3.79 | 6.72 | 4.34 | 1.23 | 1.12 | 0.49 |
Long-Term Debt | 0.04 | - | - | - | 0.14 | - |
Long-Term Leases | 0.01 | - | 0.19 | 0.25 | - | 0.05 |
Total Liabilities | 3.84 | 6.72 | 4.53 | 1.47 | 1.26 | 0.54 |
Shareholders' Equity
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Common Stock | 0.17 | 0.13 | 0.12 | 0.11 | 0.1 | 0.08 |
Additional Paid-In Capital | 35.2 | 30.52 | 28.82 | 25.33 | 19.86 | 13.97 |
Retained Earnings | -38.99 | -37.18 | -32.61 | -25.78 | -19.58 | -13.65 |
Total Common Equity | -3.62 | -6.53 | -3.67 | -0.34 | 0.38 | 0.4 |
Shareholders' Equity | -3.62 | -6.52 | -3.67 | -0.34 | 0.38 | 0.4 |
Total Liabilities & Equity | 0.22 | 0.2 | 0.86 | 1.13 | 1.64 | 0.94 |
Additional Metrics
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Total Debt | 0.61 | 3.83 | 2.82 | 0.32 | 0.21 | 0.12 |
Net Cash (Debt) | -0.58 | -3.82 | -2.82 | -0.25 | 0.43 | 0.33 |
Net Cash Growth | - | - | - | - | 31.73% | 63.06% |
Net Cash Per Share | -0.00 | -0.03 | -0.02 | -0.00 | 0.00 | 0.00 |
Filing Date Shares Outstanding | 205.51 | 216.67 | 130.49 | 113.72 | 102.22 | 82.8 |
Total Common Shares Outstanding | 168.87 | 130.49 | 122.18 | 110.86 | 98.9 | 80.95 |
Working Capital | -3.75 | -6.71 | -4.33 | -0.88 | 0.01 | -0.05 |
Book Value Per Share | -0.02 | -0.05 | -0.03 | -0.00 | 0.00 | 0.00 |
Tangible Book Value | -3.76 | -6.7 | -4.24 | -0.8 | -0.06 | 0.04 |
Tangible Book Value Per Share | -0.02 | -0.05 | -0.03 | -0.01 | -0.00 | 0.00 |